BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4058418)

  • 1. Competitive binding kinetics in ligand-receptor-competitor systems. Rate parameters for unlabeled ligands for the formyl peptide receptor.
    Sklar LA; Sayre J; McNeil VM; Finney DA
    Mol Pharmacol; 1985 Oct; 28(4):323-30. PubMed ID: 4058418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for positioning fluorescent probes and crosslinkers on formyl peptide ligands.
    Vilven JC; Domalewski M; Prossnitz ER; Ye RD; Muthukumaraswamy N; Harris RB; Freer RJ; Sklar LA
    J Recept Signal Transduct Res; 1998; 18(2-3):187-221. PubMed ID: 9651885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
    Posner RG; Fay SP; Domalewski MD; Sklar LA
    Mol Pharmacol; 1994 Jan; 45(1):65-73. PubMed ID: 8302282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils.
    Waller A; Sutton KL; Kinzer-Ursem TL; Absood A; Traynor JR; Linderman JJ; Omann GM
    Biochemistry; 2004 Jun; 43(25):8204-16. PubMed ID: 15209517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple receptor states are required to describe both kinetic binding and activation of neutrophils via N-formyl peptide receptor ligands.
    Kinzer-Ursem TL; Sutton KL; Waller A; Omann GM; Linderman JJ
    Cell Signal; 2006 Oct; 18(10):1732-47. PubMed ID: 16530386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model for ligand/receptor/G-protein dynamics and actin polymerization in human neutrophils.
    Adams JA; Omann GM; Linderman JJ
    J Theor Biol; 1998 Aug; 193(4):543-60. PubMed ID: 9745752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
    Dentino AR; Raj PA; De Nardin E
    Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes.
    Van Epps DE; Simpson S; Bender JG; Chenoweth DE
    J Immunol; 1990 Feb; 144(3):1062-8. PubMed ID: 2295813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uncoupled state of the human formyl peptide receptor.
    Gilbert TL; Prossnitz ER; Sklar LA
    J Recept Signal Transduct Res; 1999; 19(1-4):327-40. PubMed ID: 10071768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
    Higgins JD; Bridger GJ; Derian CK; Beblavy MJ; Hernandez PE; Gaul FE; Abrams MJ; Pike MC; Solomon HF
    J Med Chem; 1996 Mar; 39(5):1013-5. PubMed ID: 8676333
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of neutrophil N-formyl peptide receptors by using antibodies and fluorescent peptides.
    Loitto VM; Rasmusson B; Magnusson KE
    J Leukoc Biol; 2001 May; 69(5):762-71. PubMed ID: 11358985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand/receptor internalization: a kinetic, flow cytometric analysis of the internalization of N-formyl peptides by human neutrophils.
    Finney DA; Sklar LA
    Cytometry; 1983 Jul; 4(1):54-60. PubMed ID: 6617394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ligand-receptor interactions with the fluorescence activated cell sorter.
    Sklar LA; Finney DA
    Cytometry; 1982 Nov; 3(3):161-5. PubMed ID: 6293787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational dynamics of the formyl peptide receptor: a prototype for studies of receptor dynamics and binding pocket structure.
    Sklar LA; Fay SP; Mueller H; Freer RJ; Muthukumaraswamy N; Magde D
    Agents Actions Suppl; 1991; 35():11-6. PubMed ID: 1781416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH-oxidase response.
    Liu L; Harbecke O; Elwing H; Follin P; Karlsson A; Dahlgren C
    J Immunol; 1998 Mar; 160(5):2463-8. PubMed ID: 9498791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.
    Ye RD; Quehenberger O; Thomas KM; Navarro J; Cavanagh SL; Prossnitz ER; Cochrane CG
    J Immunol; 1993 Feb; 150(4):1383-94. PubMed ID: 8432984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor.
    Honda S; Campbell JJ; Andrew DP; Engelhardt B; Butcher BA; Warnock RA; Ye RD; Butcher EC
    J Immunol; 1994 Apr; 152(8):4026-35. PubMed ID: 7511663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple activation steps of the N-formyl peptide receptor.
    Prossnitz ER; Gilbert TL; Chiang S; Campbell JJ; Qin S; Newman W; Sklar LA; Ye RD
    Biochemistry; 1999 Feb; 38(8):2240-7. PubMed ID: 10029516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
    J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast.
    Klein C; Paul JI; Sauvé K; Schmidt MM; Arcangeli L; Ransom J; Trueheart J; Manfredi JP; Broach JR; Murphy AJ
    Nat Biotechnol; 1998 Dec; 16(13):1334-7. PubMed ID: 9853614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.